BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 01/04/2026

Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration

The National Eye Institute is contemplating the grant of an Exclusive Patent License to Perpetual Biosciences, Inc. for practicing inventions related to treating retinal degeneration.

Source: Federal Register — Health and Human ServicesOpen original release →